• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者的功能状态和健康相关生活质量与死亡率的关系。

Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis.

机构信息

University of Nebraska Medical Center, Omaha, Nebraska, USA.

出版信息

J Rheumatol. 2012 Jan;39(1):54-9. doi: 10.3899/jrheum.110491. Epub 2011 Nov 15.

DOI:10.3899/jrheum.110491
PMID:22089466
Abstract

OBJECTIVE

Patients with rheumatoid arthritis (RA) are at increased risk of death. Modern RA therapy has been shown to improve health status, but the relationship of such improvements to mortality risk is unknown. We assessed the relationship between health status and all-cause mortality in patients with RA, using the Health Assessment Questionnaire (HAQ) and the Medical Outcomes Study Short Form-36 questionnaire (SF-36) physical and mental component summary scores (PCS, MCS).

METHODS

Subjects (n = 10,319) were selected from the National Data Bank for Rheumatic Diseases, a prospective longitudinal observational US study with semiannual assessments of HAQ, PCS, and MCS. Risk of death up to 7 years through 2006 was obtained from the US National Death Index. Relationship of HAQ, PCS, and MCS to mortality was assessed using Cox regression models; prediction accuracy was compared using Harrell's concordance coefficient (C).

RESULTS

Over 64,888 patient-years of followup, there were 1317 deaths. Poorer baseline health status was associated with greater mortality risk. Adjusting for age, sex, and baseline PCS and MCS, declines in PCS and HAQ were associated with higher risk of death. HAQ improvement was associated with reduced mortality risk from 6 months through 3 years; a similar relationship was not observed for PCS or MCS improvement. Controlling for baseline values, change in PCS or HAQ did not improve prediction accuracy.

CONCLUSION

The HAQ and the SF-36 PCS are similarly and strongly associated with mortality risk in patients with RA. Change in these measures over time does not appear to add to predictive accuracy over baseline levels.

摘要

目的

类风湿关节炎(RA)患者的死亡风险增加。现代 RA 治疗已被证明可以改善健康状况,但改善健康状况与死亡风险之间的关系尚不清楚。我们使用健康评估问卷(HAQ)和医疗结果研究 36 项简短形式问卷(SF-36)的身体和心理成分综合评分(PCS、MCS)评估了 RA 患者的健康状况与全因死亡率之间的关系。

方法

从美国国立风湿病数据库(National Data Bank for Rheumatic Diseases)中选择了受试者(n=10319),这是一项前瞻性纵向观察性研究,每半年评估一次 HAQ、PCS 和 MCS。通过美国国家死亡指数获得 2006 年之前长达 7 年的死亡风险。使用 Cox 回归模型评估 HAQ、PCS 和 MCS 与死亡率的关系;使用 Harrell 一致性系数(C)比较预测准确性。

结果

在超过 64888 患者年的随访期间,有 1317 人死亡。基线健康状况越差,死亡风险越高。调整年龄、性别以及基线 PCS 和 MCS 后,PCS 和 HAQ 的下降与死亡风险的增加相关。HAQ 的改善与 6 个月至 3 年内的死亡率降低相关;但 PCS 或 MCS 的改善没有观察到类似的关系。在控制基线值的情况下,PCS 或 HAQ 的变化并没有提高预测准确性。

结论

HAQ 和 SF-36 PCS 在 RA 患者的死亡率风险方面具有相似且强烈的相关性。这些指标随时间的变化似乎并不能增加基线水平以上的预测准确性。

相似文献

1
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis.类风湿关节炎患者的功能状态和健康相关生活质量与死亡率的关系。
J Rheumatol. 2012 Jan;39(1):54-9. doi: 10.3899/jrheum.110491. Epub 2011 Nov 15.
2
What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?哪些因素影响 SF-12v2 健康调查量表和健康评估问卷测量的类风湿关节炎患者的健康状况?
J Rheumatol. 2009 Oct;36(10):2183-9. doi: 10.3899/jrheum.090134. Epub 2009 Sep 1.
3
Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.类风湿关节炎患者与普通人群相比,五年内健康评估问卷残疾评分的变化。
Arthritis Rheum. 2006 Oct;54(10):3113-8. doi: 10.1002/art.22130.
4
The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis.类风湿关节炎患者18年间功能状态及功能状态变化对死亡率的影响。
J Rheumatol. 2002 Sep;29(9):1851-7.
5
Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.大剂量化疗后自体造血干细胞移植的重症类风湿关节炎患者健康状况的长期随访
Arthritis Rheum. 2005 Aug;52(8):2272-6. doi: 10.1002/art.21219.
6
Validation of a rheumatoid arthritis health-related quality of life instrument, the CSHQ-RA.一种类风湿性关节炎健康相关生活质量工具——CSHQ-RA的验证
Arthritis Rheum. 2003 Dec 15;49(6):798-803. doi: 10.1002/art.11478.
7
EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.系统性红斑狼疮患者的 EQ-5D 和 SF-36 生活质量测量:与类风湿关节炎、非炎症性风湿性疾病和纤维肌痛的比较。
J Rheumatol. 2010 Feb;37(2):296-304. doi: 10.3899/jrheum.090778. Epub 2009 Dec 23.
8
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.身体功能与健康相关生活质量:来氟米特、柳氮磺胺吡啶或甲氨蝶呤治疗活动性类风湿关节炎患者的随机对照研究2年数据分析
J Rheumatol. 2005 Apr;32(4):590-601.
9
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.与甲氨蝶呤相比,来氟米特治疗类风湿关节炎患者后,在功能和健康相关生活质量指标方面所反映出的临床改善:在一项为期12个月的安慰剂对照试验中检测治疗效果的敏感性和相对效率。来氟米特类风湿关节炎研究组。
Arthritis Rheum. 2000 Mar;43(3):506-14. doi: 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U.
10
Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.类风湿关节炎患者的工作限制:836例患者工作限制问卷的结果、信度和效度
J Rheumatol. 2005 Jun;32(6):1006-12.

引用本文的文献

1
Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data.接受生物制剂或靶向合成疗法的类风湿关节炎患者的生存结果及预后因素:真实世界数据
Antibodies (Basel). 2025 Jun 30;14(3):54. doi: 10.3390/antib14030054.
2
The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease.疾病严重程度指标对美国类风湿关节炎相关间质性肺病退伍军人生存的影响。
Rheumatology (Oxford). 2022 Nov 28;61(12):4667-4677. doi: 10.1093/rheumatology/keac208.
3
Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path.
COVID-19 大流行期间风湿性疾病患者的生活质量:心理-社会-生物途径。
PLoS One. 2022 Jan 18;17(1):e0262756. doi: 10.1371/journal.pone.0262756. eCollection 2022.
4
Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study.影响韩国类风湿关节炎患者生活质量的因素:一项横断面研究。
Clin Rheumatol. 2022 Feb;41(2):367-375. doi: 10.1007/s10067-021-05944-9. Epub 2021 Oct 5.
5
Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis.中国达标治疗时代中重度类风湿关节炎患者生物治疗方案的成本效益分析
Clin Rheumatol. 2022 Jan;41(1):63-73. doi: 10.1007/s10067-021-05876-4. Epub 2021 Aug 10.
6
Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population.托法替布治疗中国中重度类风湿关节炎的成本效果分析:基于源自中国人群的映射算法
Adv Ther. 2021 May;38(5):2571-2585. doi: 10.1007/s12325-021-01733-7. Epub 2021 Apr 10.
7
Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure.三联疗法与生物治疗序列作为甲氨蝶呤治疗失败后类风湿关节炎患者一线治疗的成本效益
Rheumatol Ther. 2021 Jun;8(2):775-791. doi: 10.1007/s40744-021-00300-4. Epub 2021 Mar 27.
8
Developing the Korean Educational Needs Assessment Tool (Korean ENAT) in rheumatoid arthritis: cross-cultural validation using Rasch analysis.开发类风湿关节炎韩国教育需求评估工具(Korean ENAT):使用 Rasch 分析进行跨文化验证。
Korean J Intern Med. 2021 Jul;36(4):1014-1022. doi: 10.3904/kjim.2019.422. Epub 2020 Oct 30.
9
Predictors of Flares in Patients with Rheumatoid Arthritis Who Exhibit Low Disease Activity: A Nationwide Cohort Study.疾病活动度低的类风湿关节炎患者病情复发的预测因素:一项全国性队列研究。
J Clin Med. 2020 Oct 7;9(10):3219. doi: 10.3390/jcm9103219.
10
Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs.生物治疗方案在改善中重度类风湿关节炎患者中的应用:一项疾病修饰抗风湿药物治疗失败后的经济学评价的系统综述
Pharmacoeconomics. 2020 May;38(5):459-471. doi: 10.1007/s40273-020-00887-6.